Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279733 · ClinicalTrials.gov registry record
Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 4,450
- Enrollment target
NCT01279733: Completed study, sponsored by Columbia University.
NCT01279733 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 4,450 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01279733 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 4,450 participants
- Enrollment target
Study Summary
The main objective of the multi-centered collaborative study is to evaluate the accuracy, efficacy and clinical advantages of prenatal diagnosis using microarray analysis as compared with conventional karyotyping.
Primary Outcome
This is a blinded prospective comparison of microarray copy number analysis to metaphase karyotyping for the detection of common fetal cytogentic abnormalites
Interventions
- GENETIC Microarray analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,450 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-10 |
What the finished NCT01279733 record still lists
NCT01279733 is an observational study that tracks outcomes without assigning an intervention. Its 4,450 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Microarray analysis is the first listed.
NCT01279733 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01279733 about?
NCT01279733 is a clinical study titled "Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis". The main objective of the multi-centered collaborative study is to evaluate the accuracy, efficacy and clinical advantages of prenatal diagnosis using microarray analysis as compared with conventional karyotyping.
What is the current status of trial NCT01279733?
This trial is currently completed. The enrollment target is 4,450 participants. The study started on 2008-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01279733?
The interventions under investigation include: Microarray analysis (GENETIC).
Who is sponsoring clinical trial NCT01279733?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT06588452 · 4,500 participants
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia